4//SEC Filing
Kolaja Carey OConnor 4
Accession 0001479290-21-000061
CIK 0001479290other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 8:17 PM ET
Size
7.4 KB
Accession
0001479290-21-000061
Insider Transaction Report
Form 4
Kolaja Carey OConnor
Director
Transactions
- Award
Stock Option (Right to buy)
2021-03-01+11,417→ 11,417 totalExercise: $26.80Exp: 2031-02-28→ Common Stock (11,417 underlying) - Award
Common Stock
2021-03-01+6,294→ 6,294 total
Footnotes (2)
- [F1]Represents an initial restricted stock award (the "RSA") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the "Compensation Policy"). The shares underlying the RSA shall vest on the one year anniversary of the date of grant, March 1, 2022, subject to Ms. Kolaja's Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the "Plan")) through such vesting date.
- [F2]The shares subject to the stock option shall vest on the one year anniversary of the date of grant, March 1, 2022, subject to Ms. Kolaja's' Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an initial grant pursuant to the Compensation Policy.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001848717
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 8:17 PM ET
- Size
- 7.4 KB